CARL ZEISS AG

Their core work

Carl Zeiss is a major German optics and photonics manufacturer that brings industrial-grade optical engineering to EU research consortia. In H2020, they focused on advancing optical coherence tomography (OCT), bio-photonic imaging, and quantum-enhanced microscopy — translating laboratory optical concepts into compact, manufacturable devices. Their contribution centers on bridging the gap between optical science and real-world diagnostic and imaging instruments, particularly for medical and life science applications.

What they specialise in

How they've shifted over time

Carl Zeiss's early H2020 involvement (2016–2018) focused on fundamental optical technologies — photon management, bio-photonic imaging, and miniaturizing OCT systems onto chips. Their later projects (2018–2022+) show a clear shift toward applied diagnostics, with HandheldOCT explicitly targeting point-of-care diagnostics and diagnostic-driven therapy. This progression from optics research toward clinical and portable diagnostic tools reflects a strategic move from lab instrumentation toward bedside and field-deployable devices.

Zeiss is moving from laboratory optics toward compact, handheld diagnostic instruments for clinical point-of-care use — expect future interest in portable medical imaging and integrated diagnostic platforms.

How they like to work

Zeiss consistently participates as a partner rather than leading consortia — zero coordinator roles across all six projects. With 42 unique partners across 13 countries, they operate as a broad-network specialist contributor, bringing optical engineering expertise to diverse research teams rather than building their own. This pattern suggests they are a reliable industrial partner who contributes specific manufacturing and design capabilities without seeking to control project direction.

Zeiss has collaborated with 42 distinct partners across 13 countries, indicating a well-distributed European network. Their participation spans both research-excellence and digitally-focused consortia, connecting them to universities, research institutes, and other technology companies across the EU.

What sets them apart

As one of the world's leading optics manufacturers, Zeiss brings unmatched capability in turning optical research into manufacturable products — something few academic or SME partners can offer. Their H2020 portfolio shows they are specifically invested in medical optics and diagnostics, making them an ideal industrial partner for any consortium that needs to take photonic or imaging technology from prototype to product. Their consistent willingness to join as a partner (never coordinator) means they integrate into existing teams without political overhead.

Highlights from their portfolio

• HandheldOCT
  Largest Zeiss funding (EUR 995,060), most recent project, and signals their strategic direction toward portable point-of-care diagnostic devices.
• Q-MIC
  Explores quantum-enhanced microscopy, representing Zeiss's reach into quantum optics — a frontier area for next-generation measurement instruments.
• OCTCHIP
  Aims to miniaturize OCT onto a chip, showcasing Zeiss's expertise in translating complex optical systems into compact integrated devices.